Rimawi,M . F .,et al .,Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2 / neu-overexpressing breast tumor xenografts .Gianni,L .,et al .,Treatment with trastuzumab for 1 year after adjuv ......